Swiss stock up on COVID-19 vaccine reservations, adding Pfizer and COVAX

Switzerland now has reserved around 16 million doses of potential COVID-19 vaccines, the government said on Wednesday, after announcing a 3.2 million-dose reservation with a World Health Organization-led program and another 3 million-dose pact with Pfizer and BioNTech.

Switzerland previously reserved nearly 10 million doses of prospective vaccines from Moderna and AstraZeneca and has set aside 400 million Swiss francs ($435.92 million) for purchases. ($1 = 0.9176 Swiss francs)